The Prostacyclin Analogue Iloprost Modulates CXCL10 in Systemic Sclerosis
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms231710150
Abstract: The prostacyclin analogue iloprost is used to treat vascular alterations and digital ulcers, the early derangements manifesting in systemic sclerosis (SSc), an autoimmune disease leading to skin and organ fibrosis. Bioindicator(s) of SSc onset and… read more here.
Keywords: prostacyclin analogue; rheumatology; endothelial cells; iloprost ... See more keywords